跳至主要内容
临床试验/NCT05139524
NCT05139524招募中不适用

Maintenance and Transmission of Rift Valley Fever Virus and Other Emerging Infectious Diseases in East and Central Africa

Washington State University10 个研究点 分布在 4 个国家目标入组 5,000 人开始时间: 2021年10月8日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
5,000
试验地点
10
主要终点
Detection of RVF virus exposure

研究概览

简要总结

Rift Valley fever (RVF), a disease transmitted from livestock (cattle, sheep, goats, camels) to humans more commonly occurs in the East and Central Africa (ECA) regions where more than 15 major epidemics affecting more than one country have been reported over the past 50 years. Within the region, there are specific areas, referred to as hotspots, which support RVF virus maintenance via low-level virus circulation between animals, humans, and mosquitoes. Most outbreaks originate from these hotspots. Our goal is to conduct studies in RVF hotspots in four ECA countries, Kenya, Uganda, Tanzania, and Democratic Republic of Congo (DRC) to determine the burden of RVF disease among humans, wildlife and livestock during inter-epidemic periods (IEPs) and discover circulation of undetected infectious diseases. This information is important for use in developing an early warning system and possibly a vaccination strategy. The study will take place in Uganda, Kenya, Tanzania and Democratic Republic of Congo

详细描述

STUDY BACKGROUND

The East and Central Africa (ECA) region represents a unique environment to investigate RVF virus maintenance and transmission as it has reported the largest number of RVF epidemics. Recent studies have identified hotspots characterized by continuous low levels of human and livestock virus infections during the inter-epidemic periods (IEPs).

Although sheep are at highest risk of severe disease, how virus-host interactions differ between animal species is an area for further research. Seroprevalence and incidence studies at the wildlife, livestock, human interface are also important in understanding the nature of cross-species transmission. Our study will investigate the public health threat posed by RVFV during IEPs by determining the burden of human and livestock diseases, and the degree of sustained viral transmission in animal species during cryptic cycles. This will be carried out through surveillance among humans, livestock and wildlife. Understanding virus maintenance especially within the environment, vectors and wildlife populations will aid in identifying potential risk factors for RVFV infection in order to prevent future outbreaks.

While disease occurrence among animals may frequently go unnoticed due to inadequate animal surveillance systems and low levels of animal abortion, human disease may be the first indication that RVF virus amplification is occurring at high levels in a particular region . Furthermore, understanding the social aspects of disease transmission through human studies exploring human behaviour and cultural practices that lead to direct exposure to infected animal blood, tissues, secretions and excretions could provide valuable information to disease spill over dynamics . Additional knowledge of how routes for human exposure e.g. through mosquito bites or contact with infected animal products affect the immune response and disease outcomes is required . This will enhance global efforts in preparing for, and preventing, the possible spread of RVF disease to new regions.

While RVF may be an under-diagnosed cause of febrile illness within the ECA region it is important to consider the occurrence of other unknown or undiagnosed infectious diseases. Serious clinical disease due to a variety of pathogens in humans or animals is most likely missed in settings where health care access is limited and diagnostics scarce. Notably, multiple studies from the region report low levels of hospital visits, particularly among marginalized communities, including those in remote rural arid lands that have few health facilities and poorly functioning transport infrastructure that discourages traveling long distances to access health care. Over a third of suspected infectious diseases among humans go undiagnosed even when considerable testing is carried out; thus, many retrospective studies of emerging pathogens uncover cases in the region that occurred long before the pathogen was identified and epidemics reported.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Those who do not consent or refuse written consent. If a participant is severely ill and has no next of kin to provide consent +/- witness on their behalf.
  • If a participant is known to have blood clotting disorders, allergies arising from injections, or if a participant has ever fainted during previous injections or blood collection

结局指标

主要结局

Detection of RVF virus exposure

时间窗: 2 years

Detection of RVFV RNA, and IgM and IgG antibodies

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验